Transgenic ovary-targeting chitinase plants for insect infestation control

Overview

This technology uses transgenic plants to produce a chitinase fusion protein that specifically targets the ovaries of feeding insects. By degrading chitin, a primary component of insect exoskeletons and the peritrophic matrix, chitinase delivers insecticidal and antifungal effects. The innovation lies in fusing chitinase to a synthetic vitellogenin and a protein transduction domain, enabling the protein to reach the insect's reproductive system. This approach not only kills feeding insects but also reduces offspring production, providing protection to both the transgenic plant and surrounding crops. The result is a more effective and durable pest management solution that addresses the limitations of conventional chitinase applications.

Technical specifications

• Targeted chitinase delivery: Chitinase is fused to a synthetic vitellogenin carrier and a protein transduction domain, enabling gut uptake and ovary-specific targeting in feeding insects.
• Phloem-specific expression: Two transgenic tomato lines have been developed using a phloem-specific promoter to drive expression of the fusion construct, limiting protein production to vascular tissue.
• N-terminal and C-terminal configurations: Constructs are available with the protein transduction domain positioned at either end of the chitinase, allowing optimization of fusion activity and uptake efficiency.
• Molecular characterization: Transgenic lines have been screened via PCR and digital-drop PCR to confirm transgene integration and selectable marker copy number.
• Whitefly colony and bioassay platform: A lab-scale whitefly rearing methodology supports bi-weekly experimentation, enabling quantitative fecundity assessment and controlled efficacy testing.
• Antifungal potential: Plant extracts can be evaluated for inhibition of Rhizoctonia solani, a major soil-borne fungal pathogen, through dedicated bioassays.
• Quantitative validation tools: Chitinase kinetic assays and confocal microscopy of PTD-mCherry-vitellogenin fusion lines enable measurement of fusion protein activity and confirmation of vascular transport to insect ovaries.

Technology readiness level

The technology is currently at an early-to-mid stage of development. Transgenic tomato lines have been created and molecularly characterized, and a whitefly colony platform has been established for ongoing testing. Quantitative fecundity data has been collected against colony controls, but full efficacy validation remains to be completed. Future work includes direct testing against known-quantity whitefly inoculum, antifungal bioassays, enzymatic activity quantification, and visual confirmation of protein transport to insect ovaries. The technology is not yet commercially deployed and would benefit from partnerships to advance field validation and scale-up.